2 dagen geleden - NWO-institutenorganisatie - Utrecht
In this project you will develop optical metasurfaces that control the coupling and trapping of light in ultrathin high-efficiency solar cells. We will use …
Early Stage Researcher for preclinical evaluation of novel treatment of heart failure and valvular disease, as part of EU International Training Network (ITN) “Personalised In-silico Cardiology” (PIC). For more information see: http://picnet.eu.
PICwill educate young researchers (biomedical engineers) to become international experts in key areas of medical technology through a coordinated plan of individual research projects addressing specific topics in sensor+device technology and cardiac computer models to monitor function, guide therapy and aid in the diagnosing process. Multi-disciplinary dialogue and work between clinicians and biomedical engineers is crucial to address the challenges in this emerging field. By providing researchers with knowledge and training from specific toics in sensordevice technology, computational biology, biomedical engineering, research methodologies, innovation and entrepreneurship, the link betwn academic research and industry will be strengthened. The scientific and clinical goal of PIC is to improve methods for monitoring heart function and controlling pacemaker devices by miniaturized motion sensors as well as develop better diagnostic methods through personalised computer models incorporating anatomical and electrical data from each patient.
This specific PhD position is dedicated to develop and investigate independent hypotheses of the electro-mechanical cardiac physiology in large animal models. This project will build and use models of synchronous and dyssynchronous heart failure and investigate therapies for resynchronization and valvular repair. These models will be used to test hypotheses as well as the usefulness of sensors, developed in other workpackages. Measurements will include electrophysiological mapping, echocardiography, MRI and hemodynamics. More specific plans will be made at the kick-off meeting of the project, early 2018. Beside the research at CARIM, the ESR will spend secondments at at company and at another university
Temporary employment for 4 years.
Your salary would be € 2.222,- gross per month in the first year up to € 2.840,- gross per month in the fourth year according to the PhD-student salary scale.
Each year an evaluation will take place.
The terms of employment of Maastricht University are set out in the Collective Labour Agreement of Dutch Universities (CAO). Furthermore, local UM provisions also apply.
For more information look at the website www.maastrichtuniversity.nl , Support/UM employees/Employment conditions.
Prof dr Frits Prinzen, department Physiology, email@example.com
Salaries are according to standards within ITN projects. Gross monthly allowance is 3243 euro per months, from which social duties and taxes will be subtracted. Special compensations are availabel to cover costs for traveling and housing during the secondments
De Universiteit Maastricht (UM), is bekend om haar unieke, innovatieve, probleemgestuurde onderwijssysteem (PGO), dat wordt gekarakteriseerd door een kleinschalige en studentgeoriënteerde benadering. Het onderzoek aan de UM is multidisciplinair en thematisch van aard, en vindt geconcentreerd plaats in onderzoeksinstituten en schools. De UM heeft op dit moment zo'n 16.500 studenten en 4.000 medewerkers. Ten gevolge van het sterke internationale karakter is een groot deel van zowel studenten als medewerkers afkomstig uit het buitenland. De UM bestaat uit: Faculty of Health, Medicine and Life Sciences, Faculty of Law, School of Business and Economics, Faculty of Humanities and Sciences, Faculty of Arts and Social Sciences en de Faculty of Psychology and Neuroscience.CARIM - School for Cardiovascular Diseases
CARIM - School for Cardiovascular Diseases
The Cardiovascular Research Institute Maastricht (CARIM), School for Cardiovascular Diseases, is one of the top institutes for translational cardiovascular research in Europe. It is among the world leaders in the fields of research into vascular and thrombotic disorders and atrial fibrillation as well as translational heart failure research. It has also made important international contributions to molecular imaging in the cardiovascular field.
With an annual budget of approximately 22 mln Euros in 2016, CARIM is one of the largest cardiovascular research institutes in Europe, producing more than 550 scientific articles and approximately 45 PhD dissertations per year. CARIM employs 250 researchers from 13 disciplines, about 120 PhD students and 50 technical and support staff members.
Over the last ten years, CARIM papers have been published in high-impact journals such as the New England Journal of Medicine, JAMA, Nature Medicine, Nature Cell Biology, Cell Metabolism, Journal of Experimental Medicine, Circulation, Lancet Neurology, and the Journal of the American College of Cardiology. Bibliometric analyses illustrate that CARIM publications have been cited 1.97 times more often than the world average for the cardiovascular field in the period of 2009 until 2012.
CARIM is recognized by the KNAW as a research school and as an international training site for Early Stage Researchers in the framework of the Marie Curie Program.
Cardiovascular scientists from around the world join CARIM because it values open communication, close cooperation, high ambitions, good facilities and a critical learning environment.